["{\n\"step_by_step_thinking\": \"These documents describe the effects of Piribedil on patients with Parkinson's syndrome. Since the question is about pacritinib, which is not mentioned in these documents, we can safely conclude that it has no relation to this study and therefore cannot be effective for treatment of myelofibrosis.\",\n\"answer_choice\": \"B\"\n}"]